In the GLP-1 field, we have gone from twice a day, to once a day, to once a week to now once a month [Amgen]
The good news: these skin sensations were generally rated as mild, and no participants withdrew from the trial because of them
Development of Glucagon-Like Peptide 1 Receptor Agonists for the Management of Obesity Glucagon-like peptide 1 receptor agonists (GLP-1RAs), including liraglutide and semaglutide, were initially developed for the treatment of type 2 diabetes but were found to be effective not only in reducing blood glucose levels but body weight as well [18,19,20]
doi: 10.1007/s00125-017-4330-3 130 JojimaTUchidaKAkimotoKTomotsuneTYanagiKIijimaTet al
Focus on nutrient density , not portion size
Ketogenic diet in refractory migraine: Possible efficacy and role of ketone bodies-a pilot experience